- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05426772
Investigation of the Effect of Kinesiotape Applied With Exercise on Muscle Oxygenation With Moxy Muscle Oxygen Monitor
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Bandırma
-
Balıkesir, Bandırma, Turkey
- Bandırma Onyedi Eylül University Faculty of Health Sciences Department of Physiotherapy and Rehabilitation
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Volunteering to participate in the study
- Being between the ages of 18-40
- Being sedentary (<600 MET-min/week according to the International Physical Activity Questionnaire Short Form)
- BMI <30kg/cm2
- Subcutaneous fat thickness <12mm
Exclusion Criteria:
- Having an open wound or infection in the application area
- Having a chronic illness
- Being pregnant
- Having a psychological disorder
- Having a lower extremity injury in the last 6 months
- Having had any surgical operation involving the lower extremity in the last 6 months
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Healthy sedentary people
Muscle oxygenation and vital signs will be measured before, during, and after of 20 minutes aerobic exercise in an environment where suitable conditions are provided.
After 3 days, kinesio taping will be added to the same program and the measurements will be repeated.
|
Exercise: Aerobic exercise will be performed on the treadmill for 20 minutes with a maximum heart rate of 55%-65% and a perceived exertion of less than 3. The Moxy muscle oxygen monitor will take measurements over the quadriceps femoris muscle at this time. Kinesiotaping: After 3 days, the same participants will be called for kinesiotaping application. The application will be applied to the quadriceps femoris muscle with the facilitation technique by a physiotherapist who has a kinesio taping training certificate. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Moxy Muscle Oxygen Monitor
Time Frame: Baseline
|
The Moxy muscle oxygen monitor is a lightweight (42 g) and small (dimensions: 61 × 44 × 21 mm) device that measures regional blood flow and oxygenation by placing it on the skin non-invasively with near infrared spectroscopy (NIRS).
The device, which has data collection and telemetric features, also allows O2 measurement in non-laboratory environments and field-based research.
Compared to other NIRS devices, the Moxy muscle oxygen monitor has been shown to be a valid and reliable device for muscle oxygenation.
Its validity in measuring muscle oxygenation was strong or very good, and its reliability was found to be moderate to high in low-intensity exercises (SROC: r = 0.842-0.993,
ICC: r = 0.773-0.992,
p < .01).
It has been reported that as exercise intensity increases, its reliability changes inversely.
|
Baseline
|
Moxy Muscle Oxygen Monitor
Time Frame: fourth day
|
The Moxy muscle oxygen monitor is a lightweight (42 g) and small (dimensions: 61 × 44 × 21 mm) device that measures regional blood flow and oxygenation by placing it on the skin non-invasively with near infrared spectroscopy (NIRS).
The device, which has data collection and telemetric features, also allows O2 measurement in non-laboratory environments and field-based research.
Compared to other NIRS devices, the Moxy muscle oxygen monitor has been shown to be a valid and reliable device for muscle oxygenation.
Its validity in measuring muscle oxygenation was strong or very good, and its reliability was found to be moderate to high in low-intensity exercises (SROC: r = 0.842-0.993,
ICC: r = 0.773-0.992,
p < .01).
It has been reported that as exercise intensity increases, its reliability changes inversely.
|
fourth day
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
heart rate
Time Frame: Baseline
|
heart rate will be evaluated with pulse oximetry
|
Baseline
|
heart rate
Time Frame: fourth day
|
heart rate will be evaluated with pulse oximetry
|
fourth day
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
respiratory frequency
Time Frame: Baseline
|
respiratory frequency will be evaluated with pulse oximetry
|
Baseline
|
respiratory frequency
Time Frame: fourth day
|
respiratory frequency will be evaluated with pulse oximetry
|
fourth day
|
O2 saturation
Time Frame: Baseline
|
O2 saturation will be evaluated with pulse oximetry
|
Baseline
|
O2 saturation
Time Frame: fourth day
|
O2 saturation will be evaluated with pulse oximetry
|
fourth day
|
blood pressure
Time Frame: Baseline
|
blood pressure will be evaluated with sphygmomanometer.
Systolic and diastolic pressures will be assessed.
|
Baseline
|
blood pressure
Time Frame: fourth day
|
blood pressure will be evaluated with sphygmomanometer.
Systolic and diastolic pressures will be assessed.
|
fourth day
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 2020-60
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy
-
Prevent Age Resort "Pervaya Liniya"RecruitingHealthy Aging | Healthy Diet | Healthy LifestyleRussian Federation
-
Maastricht University Medical CenterCompletedHealthy Volunteers | Healthy Subjects | Healthy AdultsNetherlands
-
Yale UniversityNot yet recruitingHealth-related Benefits of Introducing Table Olives Into the Diet of Young Adults: Olives For HealthHealthy Diet | Healthy Lifestyle | Healthy Nutrition | CholesterolUnited States
-
University of PennsylvaniaActive, not recruitingHealthy | Healthy AgingUnited States
-
Chalmers University of TechnologyGöteborg UniversityCompletedHealthy | Nutrition, HealthySweden
-
Hasselt UniversityRecruitingHealthy | Healthy AgingBelgium
-
Galera Therapeutics, Inc.Syneos HealthCompleted
-
Galera Therapeutics, Inc.Syneos HealthCompletedHealthy | Healthy VolunteersAustralia
-
University of ManitobaNot yet recruitingHealthy | Healthy Diet
Clinical Trials on exercise and kinesiotaping
-
Istanbul Physical Medicine Rehabilitation Training...CompletedPain | Myofascial Pain Syndrome | Trigger Point Pain, MyofascialTurkey
-
Ahi Evran University Education and Research HospitalCompletedDistal Radius FractureTurkey
-
University of Castilla-La ManchaUnknownParkinson Disease | KinesiotapingSpain
-
Istanbul Nisantasi UniversityBezmialem Vakif University; Istanbul University - Cerrahpasa (IUC)Recruiting
-
Fundación Universidad Católica de Valencia San...Completed
-
Dilşad SindelCompletedFemale Patients With Myofascial Pain Syndrome (MPS) Related to Upper Trapezius Active Trigger Points (TP)
-
Chang Gung Memorial HospitalCompletedStroke | Upper Extremity Spasticity
-
Ignacio Alejandro Astudillo GanoraCompletedBack Pain | Lumbar Pain Syndrome | Back Pain, LowSpain
-
Cairo UniversityRecruiting